CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
25 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cidara Therapeutics, Inc....
REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
25 avr. 2024 05h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Reviva Pharmaceuticals...
AGILITI ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of AGTI and Encourages Investors to Contact the Firm
25 avr. 2024 05h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or...
LANTRONIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Lantronix, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
24 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Lantronix, Inc. (NASDAQ:...
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
23 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Tandem Diabetes Care,...
MOBILEYE ALERT: Bragar Eagel & Squire, P.C. is Investigating Mobileye Global Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
22 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Mobileye Global Inc....
Bragar Eagel & Squire, P.C. Is Investigating CI&T, Harbor, AXTI, and Morgan Stanley and Encourages Investors to Contact the Firm
19 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CI&T Inc. (NYSE:...
POWERFLEET ALERT: Bragar Eagel & Squire, P.C. is Investigating PowerFleet, Inc. on Behalf of PowerFleet Stockholders and Encourages Investors to Contact the Firm
18 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against PowerFleet, Inc....
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)
18 avr. 2024 17h03 HE
|
Kirby McInerney LLP
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ:...
AGILITI ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of HRT and Encourages Investors to Contact the Firm
18 avr. 2024 02h30 HE
|
Bragar Eagel & Squire
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or...